1996
DOI: 10.3109/02841869609101643
|View full text |Cite
|
Sign up to set email alerts
|

Generation of Human Monoclonal Antibodies Against Ganglioside Antigens and Their Applications in the Diagnosis and Therapy of Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2000
2000
2011
2011

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 42 publications
0
3
0
Order By: Relevance
“…In attempts to enhance their immunogenicity in mice, many studies have converted gangliosides to TD antigens by conjugation to proteins or incorporation into protein-enriched liposomes (1,26,31,38). Indeed, we show here that BALB/c mice immunized with GQ1b-ova liposomes do generate lowlevel anti-GQ1b responses that show characteristics of a memory response.…”
Section: Vol 70 2002 Tolerance To Gangliosides and Campylobacter Inmentioning
confidence: 65%
“…In attempts to enhance their immunogenicity in mice, many studies have converted gangliosides to TD antigens by conjugation to proteins or incorporation into protein-enriched liposomes (1,26,31,38). Indeed, we show here that BALB/c mice immunized with GQ1b-ova liposomes do generate lowlevel anti-GQ1b responses that show characteristics of a memory response.…”
Section: Vol 70 2002 Tolerance To Gangliosides and Campylobacter Inmentioning
confidence: 65%
“…These tumor cells associated GSL guided mAbs have been used in cytological and pathology exams trying to differentiate benign lesions from malignant tumors 17 . Despite promising results, so far, the use of GSLs in cancer diagnosis and treatment is still restrict to some types of tumors, such as melanomas 9,30,31 .…”
Section: Discussionmentioning
confidence: 99%
“…It has also been shown that the expression of specific gangliosides is reflected in the malignancy grade of the tumour [3,14,47,52,58]. Furthermore, human monoclonal antibodies (MAbs) to several ganglioside antigens, such as GM2, GD2, GD3 and GM3, have been explored in melanoma therapy [1].…”
Section: Introductionmentioning
confidence: 99%